Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,937	2,169	2,099	1,803	693	37
Market Cap Growth	59.18%	3.32%	16.42%	160.10%	1759.97%	9.20%
Enterprise Value	2,117	1,936	1,779	1,383	497	-32
Last Close Price	41.97	39.66	44.57	38.64	17.52	2.23
PE Ratio	-	-13.59	-18.60	-23.49	-8.69	-0.64
PS Ratio	483.91	315.12	890.64	387.68	93.45	10.43
PB Ratio	3.50	5.05	6.44	4.30	3.31	0.40
P/FCF Ratio	-22.36	-19.88	-19.89	-29.01	-16.52	-0.79
P/OCF Ratio	-22.65	-20.22	-20.24	-29.60	-17.16	-0.80
EV/Sales Ratio	348.58	281.34	754.94	297.37	67.06	-8.93
EV/EBITDA Ratio	-15.52	-13.93	-17.08	-20.93	-10.90	0.64
EV/EBIT Ratio	-15.20	-13.63	-16.61	-20.00	-10.03	0.59
EV/FCF Ratio	-18.87	-17.75	-16.86	-22.25	-11.86	0.68
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.02	0.04
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.05	-0.08	-0.08
Asset Turnover	0.01	0.02	0.01	0.01	0.04	0.03
Quick Ratio	31.44	13.69	16.41	24.71	13.81	5.62
Current Ratio	31.77	13.87	17.07	24.86	13.93	5.73
Return on Equity (ROE)	-25.39%	-37.45%	-30.13%	-22.43%	-39.41%	-46.66%
Return on Assets (ROA)	-15.73%	-21.70%	-16.79%	-12.70%	-17.27%	-24.45%
Return on Capital (ROIC)	-16.36%	-23.30%	-17.78%	-13.60%	-19.96%	-30.74%
Earnings Yield	-4.93%	-6.52%	-5.35%	-3.91%	-8.62%	-136.51%
FCF Yield	-4.12%	-5.03%	-5.03%	-3.45%	-6.05%	-126.50%
Buyback Yield / Dilution	-24.69%	-3.33%	-9.37%	-44.64%	-104.32%	-38.93%
Total Shareholder Return	-24.69%	-3.33%	-9.37%	-44.64%	-104.32%	-38.93%

Source: S&P Capital IQ. Standard template.